Virtus LifeSci Biotech Cl... (BBC)
NYSEArca: BBC
· Precio en tiempo real · USD
53.26
+0.39 (0.74%)
Al cierre: Aug 17, 2026, 3:58 PM
Virtus LifeSci Biotech Clinical Trials ETF (BBC) ETF Price, Holdings & Analysis
0.74% (1D)
| Precio de compra | 0 |
| Capitalización de mercado | n/a |
| AUM | 46.39M |
| NAV | 52.95 |
| Beta | 1.26 |
| EPS (ttm) | n/a |
| Relación PE (ttm) | n/a |
| Acciones en circulación | n/a |
| Fecha de inicio | Dec 16, 2014 |
| Precio de venta | 83.11 |
| Volumen | 8,499 |
| Volumen medio (20D) | 23,685 |
| Abierto | 52.60 |
| Cierre anterior | 52.87 |
| Rango del día | 52.53 - 53.26 |
| Rango de 52 semanas | 21.83 - 54.95 |
| Participaciones | n/a |
| Relación de gastos | 0.65% |
Acerca de BBC
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Clase de activo Equity
Símbolo bursátil BBC
Fecha de inicio Dec 16, 2014
Proveedor Virtus
Sitio web Página de inicio del fondo
Intercambio NYSEArca
Las 10 principales participaciones 11.76% de activos
| Nombre | Símbolo | Peso |
|---|---|---|
| First Tracks Biother... | TRAX | 1.67% |
| Mbx Biosciences Inc | MBX | 1.24% |
| Ataibeckley Inc | ATAI | 1.23% |
| Monopar Therapeutics... | MNPR | 1.21% |
| Definium Therapeutic... | DFTX | 1.18% |
| Xencor Inc | XNCR | 1.10% |
| Zenas Biopharma Inc | ZBIO | 1.06% |
| Uniqure Nv | QURE | 1.06% |
| Apogee Therapeutics ... | APGE | 1.02% |
| Vor Biopharma Inc Or... | VOR | 0.99% |
Dividendos Rendimiento de dividendos 1.23%
| Ex-Dividendo | Cantidad | Fecha de pago |
|---|---|---|
| Dec 22, 2025 | $0.6550 | n/a |
| Dec 20, 2024 | $0.2400 | n/a |
| Dec 20, 2023 | $0.0820 | n/a |
| Dec 20, 2017 | $0.2970 | n/a |
| Dec 21, 2015 | $0.1470 | n/a |
Página 1 de 2